Durability of Virologic Response and/or Viral Resistance Patterns in Participants With Chronic Hepatitis C Who Have Been Previously Treated With Grazoprevir (MK-5172) (MK-5172-017)

NCT01667081 · clinicaltrials.gov ↗

COMPLETED

Status

2438

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Grazoprevir

Sponsor

Merck Sharp & Dohme LLC